These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1665417

  • 1. ESGAB breakpoint determination: temafloxacin.
    Phillips I, Acar J, Baquero F, Bergan T, Forsgren A, Wiedemann B.
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
    [No Abstract] [Full Text] [Related]

  • 2. Breakpoint determination: rufloxacin.
    Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
    [No Abstract] [Full Text] [Related]

  • 3. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H, Kawazoe K, Izumi K, Ito K, Tamaya T.
    Drugs; 1995 Jul; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract] [Full Text] [Related]

  • 4. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Drugs Exp Clin Res; 1992 Jul; 18(8):311-7. PubMed ID: 1338041
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ.
    Am J Med; 1991 Dec 30; 91(6A):19S-23S. PubMed ID: 1662890
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of marbofloxacin in horses.
    Bousquet-Melou A, Bernard S, Schneider M, Toutain PL.
    Equine Vet J; 2002 Jul 30; 34(4):366-72. PubMed ID: 12117108
    [Abstract] [Full Text] [Related]

  • 7. Sparfloxacin and other new fluoroquinolones.
    Richard P, Gutmann L.
    J Antimicrob Chemother; 1992 Dec 30; 30(6):739-44. PubMed ID: 1337749
    [No Abstract] [Full Text] [Related]

  • 8. Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
    Hardy DJ.
    Am J Med; 1991 Dec 30; 91(6A):12S-14S. PubMed ID: 1662881
    [Abstract] [Full Text] [Related]

  • 9. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
    Aarestrup FM, Jensen NE, Jorsal SE, Nielsen TK.
    Vet Rec; 2000 Jan 15; 146(3):76-8. PubMed ID: 10674696
    [No Abstract] [Full Text] [Related]

  • 10. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT, Nix DE.
    Clin Pharm; 1992 Sep 15; 11(9):753-66. PubMed ID: 1325892
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N, Miyakawa Z, Kimura T, Shimizu A, Notake Y, Kunii K.
    Drugs; 1995 Sep 15; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract] [Full Text] [Related]

  • 12. [New quinolones].
    Kakeya H, Fukushima K, Saito A.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():542-8. PubMed ID: 17455678
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR.
    Am J Med; 1991 Dec 30; 91(6A):31S-34S. PubMed ID: 1662893
    [Abstract] [Full Text] [Related]

  • 14. [Experimental and clinical studies of temafloxacin in the field of obstetrics and gynecology].
    Matsuda S, Shimizu T, Cho N, Okada H.
    Jpn J Antibiot; 1993 Jun 30; 46(6):492-504. PubMed ID: 8395608
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL, Jones RN.
    J Antimicrob Chemother; 1989 Apr 30; 23(4):527-35. PubMed ID: 2745259
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of anaerobic bacteria to temafloxacin.
    Southern PM, Patel S.
    Clin Infect Dis; 1993 Jun 30; 16 Suppl 4():S334. PubMed ID: 8391861
    [No Abstract] [Full Text] [Related]

  • 17. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F.
    Clin Pharmacokinet; 1992 Jun 30; 22 Suppl 1():57-63. PubMed ID: 1319872
    [Abstract] [Full Text] [Related]

  • 18. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN, Iakovlev VP.
    Antibiot Khimioter; 1998 Jun 30; 43(2):30-9. PubMed ID: 9551171
    [No Abstract] [Full Text] [Related]

  • 19. [Review [new antimicrobial agent series XLI]: lomefloxacin].
    Soejima R, Matsumoto F.
    Jpn J Antibiot; 1991 Oct 30; 44(10):1045-60. PubMed ID: 1662290
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
    Zabinski RA, Vance-Bryan K, Krinke AJ, Walker KJ, Moody JA, Rotschafer JC.
    Antimicrob Agents Chemother; 1993 Nov 30; 37(11):2454-8. PubMed ID: 8285633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.